Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Capital Employed (2019 - 2025)

Dna X filings provide 7 years of Return on Capital Employed readings, the most recent being 90.58% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 53154.0% to 90.58% in Q4 2025 year-over-year; TTM through Dec 2025 was 90.58%, a 53154.0% increase, with the full-year FY2025 number at 87.07%, up 16175.0% from a year prior.
  • Return on Capital Employed hit 90.58% in Q4 2025 for Dna X, down from 230.67% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 230.67% in Q3 2025 to a low of 440.97% in Q4 2024.
  • Median Return on Capital Employed over the past 5 years was 68.39% (2024), compared with a mean of 92.02%.
  • Biggest five-year swings in Return on Capital Employed: crashed -44300bps in 2024 and later soared 53154bps in 2025.
  • Dna X's Return on Capital Employed stood at 203.69% in 2021, then skyrocketed by 61bps to 80.36% in 2022, then skyrocketed by 103bps to 2.04% in 2023, then plummeted by -21744bps to 440.97% in 2024, then soared by 121bps to 90.58% in 2025.
  • The last three reported values for Return on Capital Employed were 90.58% (Q4 2025), 230.67% (Q3 2025), and 7.87% (Q2 2025) per Business Quant data.